Floatz logo

3-N-BUTYLPHTHALIDE

Transient Ischemic Attack

Peking Union Medical College HospitalSmall moleculePhase 4 / ApprovedDormant
B
62/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
81/ 100

Competitive context

21 Active assets in the Transient Ischemic Attack cohort.

Asset / SponsorPhaseRating
Plavix
Sichuan Provincial People's Hospital
Phase 4BBB
Acetylsalicylic Acid
Sichuan Provincial People's Hospital
Phase 4BBB
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril
Stanford University
Phase 4BBB
Ticagrelor
Mazandaran University of Medical Sciences
Phase 3BBB
Rivaroxaban
General Hospital of Shenyang Military Region
Phase 4BBB

View all 45 →

Same molecule, other indications

3-N-BUTYLPHTHALIDE is also rated in:

ischemic strokeDormant
BBB
Indicative ·
72 / 100
View asset →
transient ischemic attackDormant
BBB
Indicative ·
72 / 100
View asset →
Collateral CirculationDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →